Aortic ornithine decarboxylase activity in deoxycorticosterone/salt hypertensive rats.
Previous studies from our own and other laboratories have shown that hypertension induces changes in the growth of arterial smooth muscle cells (SMC). The purpose of this study was to examine the role of ornithine decarboxylase (OrnDCase) in this process. OrnDCase, the rate limiting enzyme in polyamine biosynthesis, increases in activity early in the cell cycle, and has been used as a marker of cell growth or proliferation. Deoxycorticosterone (DOC)/salt hypertension was induced in male Wistar rats. At 1-3 day intervals of DOC/salt treatment, the aortas were removed and OrnDCase activity and DNA content were determined. The results indicated that OrnDCase activity increased as early as day 2 of DOC/salt administration, reached a peak at day 10, and fell to a baseline by day 16. DNA content increased after day 10 to levels approximately 25% greater than in controls. Significant increases in blood pressure were not observed until after day 8. The findings indicate that OrnDCase activity is stimulated by DOC/salt even before the rise in blood pressure and that factors other than blood pressure per se may be important in stimulating aortic smooth muscle cell growth in the development of hypertension.
Leitschuh
M
M
Whitaker Cardiovascular Institute, Boston University School of Medicine, Mass. 02118.
Hingorani
V
V
Brecher
P
P
Chobanian
A V
AV
D000818:Animals; D001011:Aorta / Q000201:enzymology*; D001794:Blood Pressure / Q000187:drug effects; D004247:DNA / Q000032:analysis; D003900:Desoxycorticosterone; D006973:Hypertension / Q000139:chemically induced / Q000201:enzymology*; D008297:Male; D009955:Ornithine Decarboxylase / Q000378:metabolism*; D051381:Rats; D011919:Rats, Inbred Strains; D012965:Sodium Chloride / Q000494:pharmacology*
D003900:Desoxycorticosterone; D012965:Sodium Chloride; D004247:DNA; D009955:Ornithine Decarboxylase